Memorial Sloan Kettering Cancer Center @MSKCancerCenter · 21 Aug 2026
New clinical trial data led by MSK’s Dr. Robert Motzer supports a novel combination therapy for patients with advanced clear cell renal cell carcinoma whose disease progressed after immunotherapy. The findings, published in @TheLancet, point to a potential new treatment option. https://t.co/WwRMH0fPAw
4 775Views
29Likes
9Reposts
3Replies
0Quotes
4Bookmarks
Is that a lot?
2.12×vs this author's median2 254 views is typical
67Percentile for this authorof 6 recent posts
0.77×vs 100K–1M median6 178 views is typical
4.59%Reachviews ÷ followers
0.86%Engagement rateof viewers reacted